Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study

OBJECTIVES: The purpose of this study was to assess the safety and performance of Stellarex Drug‐coated balloon (DCB). BACKGROUND: DCB coatings differ in excipients, paclitaxel dose, and coating morphologies. Due to these differences, a class effect with DCBs has not been demonstrated. Consequently,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroë, Herman, Holden, Andrew H., Goueffic, Yann, Jansen, Shirley J., Peeters, Patrick, Keirse, Koen, Ito, Wulf, Vermassen, Frank, Micari, Antonio, Blessing, Erwin, Jaff, Michael R., Zeller, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Peripheral Vascular Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836976/
https://www.ncbi.nlm.nih.gov/pubmed/29086462
http://dx.doi.org/10.1002/ccd.27348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836976/
https://www.ncbi.nlm.nih.gov/pubmed/29086462
http://dx.doi.org/10.1002/ccd.27348

Ejemplares similares